Catalyst Wire Dossier Catalyst Wire Dossier

VIVELLE-DOT

ESTRADIOL · Sandoz Inc
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for VIVELLE-DOT, covering 2013-04-24 to 2024-02-15. Get the full timeline:

Most recent: FDA Approved: VIVELLE-DOT — Supplemental Application (Sandoz Inc)

See pricing